After more than a year of intensive work, coordination, and communication with French regulatory authorities, Belinka Perkemija has successfully obtained an extension of the biocidal product authorization for BELOX in France. BELOX is a hydrogen peroxide-based biocidal product intended for disinfection in various industrial applications.

This authorization extension represents an important milestone for the company and expands the market opportunities for one of our key value-added products. France is a large and strategically important market where initial commercial activities have already been established. Our long-term objective is to gradually expand our presence and provide comprehensive supply of biocidal products to the French market.

The successful completion of the authorization process opens a new sales channel with significant potential and further strengthens Belinka Perkemija’s international presence in the biocidal products sector. It is an important achievement that demonstrates the expertise, persistence, and effective collaboration between R&D, product management, and commercial teams.